News and Stories2018-11-20T16:23:24+00:00

TB CARE II IPT Toolkit Featured at the 49th Union World Conference on Lung Health

The TB CARE II project was featured at the 49th Union World Conference on Lung Health, held in The Hague, The Netherlands from 24-27 October 2018. Specifically, the project’s work in isoniazid preventive therapy (IPT), a Tuberculosis (TB) preventive treatment given to children and people living with HIV, was featured in the Conference’s Prevention Press Conference on Thursday, 25-October 2018. Dr. Lisa Adams from the Dartmouth College Geisel School

USAID and Department of Health Launch $50M Projects to Fight TB

            Office of Health             PHILIPPINES HEALTH HIGHLIGHTS             Lung Month Special USAID and Department of Health Launch $50M Projects to Fight TB The U.S. Government, represented by U.S. Embassy’s Deputy Chief of Mission Michael Klecheski and USAID/Philippines Mission Director Lawrence Hardy II, and the Philippine Government, represented by Department of Health Secretary Francisco Duque

TB CARE II Partners

In order to accelerate TB implementation in high burden countries, the TB CARE II project has formed partnerships with a range of different types of implementing partners who contribute their specialized expertise in areas such as laboratory strengthening, information technology, or commodities management to supplement and assist field programs and global activities: Brigham and Women’s Hospital McGill University Partners In Health (PIH) BEA Enterprises, Inc. (BEA)

University Research Co., LLC (URC)

University Research Co., LLC (URC) is a management consulting firm based in Bethesda, MD. Founded in 1965, URC has demonstrated technical capacity improving TB control and prevention strategies globally by strengthening health systems, implementing quality improvement methodologies, developing clinical and programmatic policies and guidelines for TB and MDR TB, integrating HIV and TB services, and supporting the expansion and improvement of DOTS. URC is the prime holder of the

TB CARE II INTRODUCES FIELD GUIDE FOR THE MANAGEMENT OF MULTIDRUG-RESISTANT TB IN CHILDREN

TB CARE II recently introduced a new field guide on the management of pediatric Multidrug-Resistant Tuberculosis (MDR-TB) at the Union World Conference. This guide is the first of its kind to address the neglected issue of drug-resistant TB among children and was developed in coordination with the Sentinel Project on Pediatric Drug-Resistant Tuberculosis at Harvard University. Compiled by a group of experts with years of experience in treating children

INCLUSION OF TB IN NATIONAL INSURANCE PROGRAMS

In 2011-2012, the USAID TB CARE II project implemented by University Research Co., (URC) undertook a series of case studies to examine the extent to which TB has been integrated into National Health Insurance (NHI) programs in several high burden TB countries and to analyze the impact of NHI on achievement of National TB Control objectives. Assessments were carried out in four countries: Thailand, Peru, Phillippines, and India. Each

ASSESSMENTS OF PROVIDERS ADHERENCE TO TB EVIDENCE BASED STANDARDS AND GUIDELINES IN BANGLADESH, ZAMBIA, AND KENYA

Despite the availability of TB guidelines/ standards in high burden TB countries, provider adherence remains a challenge. In most cases, provider adherence to guidelines is not a problem of individual performance, but a problem located in the health system itself – at the political, health services, community, and patient levels. Between 2011-2012, TB CARE II conducted multi-country studies in Bangladesh, Zambia, and Kenya to gather information on: (1) Knowledge

TECHNICAL BRIEF: TACKLING TB AMONG CHILDREN

The USAID TB CARE II Project recently released a technical brief focused on tackling pediatric Tuberculosis (TB). The brief outlines specific gaps in pediatric TB management emphasizes which steps should be taken to reduce the number of pediatric TB cases, and outlines the TB CARE II project's specific accomplishments and goals in relation to this subject. To read the full brief, click here.

TB CARE II INTRODUCES HIGH LEVEL WORKSHOP TO CLOSE THE GAP ON DRUG-RESISTANT TB AMONG CHILDREN

Globally, few children with drug-resistant (DR) tuberculosis (TB) are identified, diagnosed, and given an appropriate treatment. Although advances have been made in critical high burden countries such as Bangladesh to increase access to quality care and treatment for DR TB, this disease is still considered largely to be a problem for adults, and children who are infected remain too often in the shadows, unable to access care. A child

MEDIA SPOTLIGHT: TB CARE II CONFERENCE FEATURED IN NEWS ARTICLE

The USAID funded TB CARE II Project, along with participants from the USAID TB Program South Africa, ILO, and the TB CARE I Project recently gathered together in Pretoria, South Africa to host a conference focused on improving the response to TB and TB/HIV workplace health in Southern Africa.  The conference brought together about 40 diverse stakeholders, from policymakers to members of businesses and civil society agencies, in the

Chat with TB CARE II
Powered by TB CARE II